SPIONs/3D SiSBA-16 Based Multifunctional Nanoformulation for Target Specific Cisplatin Release in Colon and Cervical Cancer Cell Lines

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-51051-w
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Curcumin Nanoformulation for Cervical Cancer Treatment

Scientific Reports
Multidisciplinary
2016English

Smart Nanoformulation Based on Stimuli-Responsive Nanogels and Curcumin: Promising Therapy Against Colon Cancer

ACS Omega
ChemistryChemical Engineering
2020English

Smart Nanoformulation Based on Stimuli-Responsive Nanogels and Curcumin: Promising Therapy Against Colon Cancer

English

ErbB3 Expression Predicts Sensitivity to Elisidepsin Treatment: In�vitro Synergism With Cisplatin, Paclitaxel and Gemcitabine in Lung, Breast and Colon Cancer Cell Lines

International Journal of Oncology
Cancer ResearchOncology
2012English

Metformin Enhances the Radiosensitizing Effect of Cisplatin in Non-Small Cell Lung Cancer Cell Lines With Different Cisplatin Sensitivities

Scientific Reports
Multidisciplinary
2019English

Efficacy of Targeted Drugs in Germ Cell Cancer Cell Lines With Differential Cisplatin Sensitivity

PLoS ONE
Multidisciplinary
2017English

Involvement of PPARs in Cell Proliferation and Apoptosis in Human Colon Cancer Specimens and in Normal and Cancer Cell Lines

PPAR Research
Drug DiscoveryPharmacology
2007English

Drug Sensitivity in Cancer Cell Lines Is Not Tissue-Specific

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2015English

Sulforaphane Induces Cell Type-Specific Apoptosis in Human Breast Cancer Cell Lines

Molecular Cancer Therapeutics
Cancer ResearchOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy